Who is sponsoring NCT05390398?

NCT05390398 is sponsored by Wageningen University.

What drugs are being tested in NCT05390398?

Interventions in NCT05390398: Behaviour change guided lifestyle intervention.

What condition does NCT05390398 study?

NCT05390398 studies Colorectal Cancer, Cancer-related Fatigue, Colon Cancer, Rectal Cancer.

Is NCT05390398 still recruiting?

NCT05390398 is currently completed. Last updated 28 March 2025.

Last reviewed 2025-03-28 · How we verify

NCT05390398: SoFiT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study on Fatigue in Colorectal Cancer Survivors, a Lifestyle Intervention

Completed NA Last updated 28 March 2025

What this trial tests

NA trial testing Behaviour change guided lifestyle intervention in Colorectal Cancer in 161 participants. Completed in 31 December 2024.

Timeline

18 January 2022

Primary endpoint
30 June 2024

31 December 2024

Quick facts

Lead sponsor	Wageningen University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	161
Start date	18 January 2022
Primary completion	30 June 2024
Estimated completion	31 December 2024
Sites	1 location across Netherlands

Drugs / interventions tested

Behaviour change guided lifestyle intervention

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →
Cancer-related Fatigue — all drugs for Cancer-related Fatigue →
Colon Cancer — all drugs for Colon Cancer →
Rectal Cancer — all drugs for Rectal Cancer →

Sponsor

Wageningen University

Who can join

18 and older, any sex, with Colorectal Cancer or Cancer-related Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The SoFiT study is a randomized controlled trial examining the effects of a behaviour change guided lifestyle intervention on increasing adherence to the World Cancer Research Fund cancer prevention guidelines, compared to the wait-list usual care group, on diminishing cancer-related fatigue in colorectal cancer survivors.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A randomised controlled intervention trial to study the effect of a personalised lifestyle programme on cancer-related fatigue among colorectal cancer survivors: protocol for the SoFiT study.
de Vries-Ten Have J, Manusama K, Verkaar AJCF, Beijer S, et al · · 2024 · PMID 38804183 · DOI 10.1017/s0007114524001107

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other Wageningen University trials

Trials by the same sponsor.

NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
NCT07421466 — Umami Taste Intensity and Meal Intake · NA · completed
NCT07075991 — Uptake and Excretion of a Single Dose of Oral 14C-labelled Polystyrene Microplastics in Healthy Volunteers · NA · completed
NCT07059117 — Umami Taste Intensity and ad Libitum Meal Intake · NA · completed
NCT06750497 — Forearm Immobilization in T2D · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05390398 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Wageningen University
Last refreshed: 28 March 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05390398.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing